Benzinga

Benzinga

Benzinga

vendredi, août 28

Zimmer Biomet Holdings Inc

ZBHNYSE
Trade with Public
Trade with Public
$100.91
1.431.44%
À la clôture: Aug 28, 5:00 PM EST
$100.91
N/A
Après les heures: 4:00 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatDividendesComparerOptionsRapport sur les stocks

Zimmer Biomet Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Zimmer Biomet Holdings (ZBH).

Price Target Range — 10 Quarters

Analyst Consensus — 23 Analysts

2S.Buy
7Buy
13Hold
1Sell
Consensus RatingNeutral# Analysts23Avg. Consensus PT$107Upside to Avg. PT+6.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 10, 2026Canaccord GenuityCaitlin RobertsPT RaiseHold$83→$100
Aug 7, 2026Truist SecuritiesRichard NewitterPT RaiseHold$92→$106
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Canaccord Genuity Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $100

Canaccord Genuity analyst Caitlin Roberts maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $83 to $100.
Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106

Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and raises the price target from $92 to $106.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110

RBC Capital analyst Shagun Singh maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price target from $101 to $110.
Benzinga Newsdesk

PRO
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93

Bernstein analyst Lee Hambright maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform and raises the price target from $91 to $93.
Benzinga Newsdesk

PRO
Stifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $110

Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $105 to $110.
Benzinga Newsdesk

PRO
BMO Capital Initiates Coverage On Zimmer Biomet Holdings with Market Perform Rating, Announces Price Target of $95

BMO Capital analyst Vik Chopra initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Market Perform rating and announces Price Target of $95.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved